IOVS Hypertension
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-2075 on July 24, 2008
(Investigative Ophthalmology and Visual Science. 2008;49:5434-5440.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.08-2075

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-2075v1
49/12/5434    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Siemasko, K. F.
Right arrow Articles by Stern, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siemasko, K. F.
Right arrow Articles by Stern, M. E.

In Vitro Expanded CD4+CD25+Foxp3+ Regulatory T Cells Maintain a Normal Phenotype and Suppress Immune-Mediated Ocular Surface Inflammation

Karyn F. Siemasko,1 Jianping Gao,1 Virginia L. Calder,2 Rebecca Hanna,1 Margarita Calonge,3 Stephen C. Pflugfelder,4 Jerry Y. Niederkorn,5 and Michael E. Stern1,4

From 1Allergan, Inc., Irvine, California; the 2University College London, London, United Kingdom; 3IOBA (Institute of Applied Ophthalmobiology), University of Valladolid, Valladolid, Spain; the 4Baylor College of Medicine, Houston, Texas; and the 5Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.

PURPOSE. To determine whether in vitro expanded CD4+CD25+Foxp3+ regulatory T cells can suppress immune-mediated ocular surface inflammation in a mouse model of dry eye.

METHODS. C57BL/6 or BALB/c mice were exposed to a dry, desiccating environment produced by maintaining low humidity (<40%), injections of scopolamine, and air flow produced by a fan. CD4+CD25+ regulatory T cells were isolated and expanded in vitro in the presence of rmIL-2 and beads coated with anti-CD28 and anti-CD3. In vitro expanded regulatory T cells were phenotypically compared with freshly isolated regulatory T cells by flow cytometry and immunofluorescence. T-cell-deficient nude mice were reconstituted with CD4+ T-effector cells from donor mice exposed to a desiccating environment for 5 days, in combination with or without freshly isolated or in vitro expanded regulatory T cells. Tear cytokine levels were determined by a multiplex bead-based immunoassay.

RESULTS. In vitro regulatory T cells maintained normal levels of CD4+, CD25+, and intracellular Foxp3+, as determined by flow cytometry and immunohistochemistry. Freshly isolated and in vitro regulatory T cells were titrated in the presence of CD4+ pathogenic T cells (CD4+Path T cells) in reconstitution experiments and most efficiently ablated tear cytokine levels and conjunctival cellular infiltration at a ratio of 1:1 (T Regs:CD4+Path).

CONCLUSIONS. Regulatory T cells expressed CD4+, CD25+, and intracellular Foxp3+ at normal levels and retained their inhibitory function after in vitro expansion, providing a useful tool to determine the mechanism regulatory T cells use to sustain a homeostatic environment on the ocular surface.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology